Cycrimine
Clinical data | |
---|---|
License data | |
ATC code | none |
Identifiers | |
| |
CAS Number | 77-39-4 |
PubChem (CID) | 2911 |
DrugBank | DB00942 |
ChemSpider | 2808 |
UNII | 543567RFQQ |
ChEBI | CHEBI:59692 |
ChEMBL | CHEMBL1201227 |
ECHA InfoCard | 100.000.932 |
Chemical and physical data | |
Formula | C19H29NO |
Molar mass | 287.4 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.[1]
Synthesis
See also
References
- ↑ Psychotropic Drugs and Related Compounds, 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972, page 218
- ↑ Denton, J. J.; Schedl, H. P.; Lawson, Virginia A.; Neier, W. B. (1950). "Antispasmodics. VII.1 Additional Morpholinyl and Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795–3796. doi:10.1021/ja01164a127.
External links
- Cycrimine at DrugLib.com
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.